Dermata Therapeutics, Inc. Warrant
DRMAW
DRMAW
4 hedge funds and large institutions have $7.29K invested in Dermata Therapeutics, Inc. Warrant in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$34 |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$232 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $7.02K | 12,000 | – | – |
|
|
TSS
2
Two Sigma Securities
New York
| $232 | 13,115 | -100 | -0.8% |
|
|
3
UBS Group
Zurich,
Switzerland
| $34 | 1,880 | -737 | -28% |
|
|
VF
4
Virtu Financial
New York
| $0 | 10,856 | +10,856 | New |
|